+7,836.4%
NVDA vs EMR
+279.2%
+7,557.2%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.0% | 0.0% | -2.0% | -2.0% |
| 7D | -12.7% | +2.8% | -15.6% | -14.5% |
| 30D | -26.4% | +3.7% | -30.1% | -28.2% |
| 3M | -27.6% | +2.0% | -29.7% | -28.8% |
| 6M | -27.7% | +22.1% | -49.8% | -37.2% |
| YTD | -12.5% | +27.2% | -39.7% | -27.8% |
| 1Y | -12.6% | +32.0% | -44.7% | -29.9% |
| 3Y | +235.9% | +103.3% | +132.7% | +98.1% |
| 5Y | +438.2% | +88.2% | +350.0% | +235.9% |
| All | +7,836.4% | +279.2% | +7,557.2% | +3,054.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling